Phage Therapy—Challenges, Opportunities and Future Prospects
Pharmaceuticals · 22.11.2023 · 16 (12) · 1638
DOI: 10.3390/ph16121638 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.11.2023. Verfasst von Beata Zalewska-Piątek. Beteiligte Einrichtung: Department of Molecular Biotechnology and Microbiology, Chemical Faculty, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland. Die Arbeit wurde bisher 179-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chemical Faculty of the Gdańsk University of Technology.
Abstract (Originalsprache)
The increasing drug resistance of bacteria to commonly used antibiotics creates the need to search for and develop alternative forms of treatment. Phage therapy fits this trend perfectly. Phages that selectively infect and kill bacteria are often the only life-saving therapeutic option. Full legalization of this treatment method could help solve the problem of multidrug-resistant infectious diseases on a global scale. The aim of this review is to present the prospects for the development of phage therapy, the ethical and legal aspects of this form of treatment given the current situation of such therapy, and the benefits of using phage products in persons for whom available therapeutic options have been exhausted or do not exist at all. In addition, the challenges faced by this form of therapy in the fight against bacterial infections are also described. More clinical studies are needed to expand knowledge about phages, their dosage, and a standardized delivery system. These activities are necessary to ensure that phage-based therapy does not take the form of an experiment but is a standard medical treatment. Bacterial viruses will probably not become a miracle cure—a panacea for infections—but they have a chance to find an important place in medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Microbiology, Chemical Faculty, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.
ORCID-Profile: Beata Zalewska-Piątek
Förderung
- Chemical Faculty of the Gdańsk University of Technology
Zitieren
APA
Zalewska-Piątek, B. (2023). Phage Therapy—Challenges, Opportunities and Future Prospects. Pharmaceuticals, 16(12), 1638. https://doi.org/10.3390/ph16121638
Vancouver
Zalewska-Piątek B. Phage Therapy—Challenges, Opportunities and Future Prospects. Pharmaceuticals. 2023;16(12):1638. doi:10.3390/ph16121638
BibTeX
@article{ZalewskaPitek2023,
author = {Zalewska-Piątek, Beata},
title = {Phage Therapy—Challenges, Opportunities and Future Prospects},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {12},
pages = {1638},
doi = {10.3390/ph16121638}
}
EUVIMED